We narrowed to 242 results for: ATO

1. pAAV-S5E2-dTom-nlsdTom (AAV1)

   Viral Prep

   #135630-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-S5E2-dTom-nlsdTom (AAV9)

   Viral Prep

   #135630-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Nov. 29, 2021

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-S5E6-dTom-nlsdTom (AAV1)

   Viral Prep

   #135641-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-S5E6-dTom-nlsdTom (#135641). In addition to the viral particles, you will also receive purified pAAV-S5E6-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato in VIP cortical interneurons under the control of the E6 regulatory element. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Feb. 6, 2025

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-S5E2-dTom-nlsdTom (AAV PHP.eB)

   Viral Prep

   #135630-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-S5E2-dTom-nlsdTom (#135630). In addition to the viral particles, you will also receive purified pAAV-S5E2-dTom-nlsdTom plasmid DNA. Bicistronic expression of dTomato and nuclear-targeted dTomato under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Jordane Dimidschstein

   Article

   Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

   Tags

   dTomato

   Available Since

   Oct. 28, 2021

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV1)

   Viral Prep

   #100832-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter, Loren Looger

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV9)

   Viral Prep

   #100832-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter, Loren Looger

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Available Since

   April 17, 2018

   Availability

   Academic Institutions and Nonprofits only

7. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV5)

   Viral Prep

   #100832-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter, Loren Looger

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV.cTNT.iCre (AAV9)

   Viral Prep

   #69916-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.cTNT.iCre (#69916). In addition to the viral particles, you will also receive purified pAAV.cTNT.iCre plasmid DNA. cTnT driven in vivo expression of Cre and tdTomato (separated by IRES sequence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   William Pu

   Article

   Lin et al Circ Res. 2015 Jan 2;116(1):35-45. doi:

   Promoter

   Chicken cardiac troponin T

   Tags

   tdTomato

   Available Since

   July 31, 2025

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CAG-NIR-GECO2G (AAV2)

   Viral Prep

   #159605-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Robert Campbell

   Article

   Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

   Promoter

   CAG

   Available Since

   Dec. 18, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-CAG-NIR-GECO2G (AAV9)

    Viral Prep

    #159605-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Robert Campbell

    Article

    Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

    Promoter

    CAG

    Available Since

    Dec. 18, 2024

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-CAG-NIR-GECO2G (AAV1)

    Viral Prep

    #159605-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Robert Campbell

    Article

    Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

    Promoter

    CAG

    Available Since

    Dec. 18, 2024

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hsyn-ASAP5-Kv2.1-WPRE (AAV1)

    Viral Prep

    #225707-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hsyn-ASAP5-Kv2.1-WPRE (#225707). In addition to the viral particles, you will also receive purified pAAV-hsyn-ASAP5-Kv2.1-WPRE plasmid DNA. Syn-driven, soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Michael Lin

    Article

    Hao et al Neuron. 2024 Sep 17:S0896-6273(24)00643-

    Promoter

    Syn

    Available Since

    Aug. 6, 2025

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-hSyn-JEDI-2P-WPRE (AAV9)

    Viral Prep

    #179464-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-JEDI-2P-WPRE (#179464). In addition to the viral particles, you will also receive purified pAAV-hSyn-JEDI-2P-WPRE plasmid DNA. hSyn-driven expression of the genetically encoded voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Francois St-Pierre

    Article

    Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

    Promoter

    Syn

    Available Since

    Jan. 24, 2024

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-hsyn-flex-Voltron-ST (AAV1)

    Viral Prep

    #119036-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-hsyn-flex-Voltron-ST (#119036). In addition to the viral particles, you will also receive purified pAAV-hsyn-flex-Voltron-ST plasmid DNA. Synapsin-driven, cre-dependent expression of genetically encoded fluorescent voltage indicator Voltron1 with a soma-targeting sequence. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Eric Schreiter

    Article

    Abdelfattah et al Science. 2019 Aug 1. pii: science.aav641

    Promoter

    Syn

    Available Since

    April 10, 2019

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-hSyn-JEDI-2P-Kv-WPRE (AAV9)

    Viral Prep

    #179463-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-JEDI-2P-Kv-WPRE (#179463). In addition to the viral particles, you will also receive purified pAAV-hSyn-JEDI-2P-Kv-WPRE plasmid DNA. hSyn-driven expression (soma and AIS-localized) of the genetically encoded voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Francois St-Pierre

    Article

    Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

    Promoter

    Syn

    Available Since

    Jan. 24, 2024

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (AAV9)

    Viral Prep

    #225708-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (#225708). In addition to the viral particles, you will also receive purified pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Michael Lin

    Article

    Hao et al Neuron. 2024 Sep 17:S0896-6273(24)00643-

    Promoter

    EF1α

    Available Since

    Sept. 22, 2025

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-EF1a-DIO-JEDI-2P-WPRE (AAV1)

    Viral Prep

    #179460-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-DIO-JEDI-2P-WPRE (#179460). In addition to the viral particles, you will also receive purified pAAV-EF1a-DIO-JEDI-2P-WPRE plasmid DNA. EF1a-driven, Cre-dependent expression of voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Francois St-Pierre

    Article

    Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

    Promoter

    EF1a

    Tags

    cEGFP (Cre-dependent)

    Available Since

    Aug. 22, 2022

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE (AAV1)

    Viral Prep

    #179459-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE (#179459). In addition to the viral particles, you will also receive purified pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma and AIS-localized expression of voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Francois St-Pierre

    Article

    Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

    Promoter

    EF1a

    Tags

    cEGFP (Cre-dependent)

    Available Since

    Aug. 23, 2022

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-Ef1a-fDIO-JRGECO1a (AAV1)

    Viral Prep

    #128317-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO-JRGECO1a (#128317). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-JRGECO1a plasmid DNA. EF1a-driven, Flp-dependent expression of the biosensor jRGECO1a. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Patricia Jensen

    Promoter

    EF1a

    Available Since

    March 18, 2024

    Availability

    Academic Institutions and Nonprofits only

20. pACAGW-ChR2-Venus-AAV (AAV1)

    Viral Prep

    #20071-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karel Svoboda

    Article

    Leopoldo et al Nature. 2009 Jan 18.

    Promoter

    CAGG

    Tags

    Venus

    Available Since

    Feb. 21, 2018

    Availability

    Academic Institutions and Nonprofits only